This inventor holds 2 USPTO granted patents. Top assignee: University of Georgia Research Foundation Inc. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Varughese Alexander Mulamootttil: Innovator in Carbocyclic Nucleoside Synthesis
Introduction
Varughese Alexander Mulamootttil is a notable inventor based in Athens, GA (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of carbocyclic nucleosides. With a total of 2 patents, his work has implications for pharmaceutical development and research.
Latest Patents
Mulamootttil's latest patents include the synthesis of 2'-fluoro-6′-methylene-carbocyclic adenosine (FMCA) and 2′-fluoro-6′-methylene-carbocyclic guanosine (FMCG). This invention provides a new convergent approach for synthesizing these compounds from readily available starting materials in just eight steps. Additionally, he has developed an efficient methodology for the stereospecific preparation of a versatile carbocyclic key intermediate, (1S,3R,4R)-3-tert-butoxy-4-(tert-butoxymethyl)-2-fluoro-5-methylenecyclopentanol, in only six steps. Prodrugs of these compounds have also been prepared, showcasing the practical applications of his research.
Career Highlights
Mulamootttil is affiliated with the University of Georgia Research Foundation, Inc., where he continues to advance his research in nucleoside synthesis. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and development of new therapeutic agents.
Collaborations
He has collaborated with esteemed colleagues such as Chung K Chu and Ram C Mishra, further enhancing the impact of his work through shared expertise and knowledge.
Conclusion
Varughese Alexander Mulamootttil's contributions to the field of chemistry, particularly in the synthesis of carbocyclic nucleosides, highlight his role as an influential inventor. His innovative methodologies and collaborative efforts continue to pave the way for advancements in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile